Neuropsychological profile of methamphetamine users, based on emotional regulation and personality traits
DOI:
https://doi.org/10.35319/ajayu.201113Keywords:
Neuropsychology, personality, emotion, methamphetamineAbstract
Compulsive and continuous use of methamphetamine can cause a certain functional disorder of neuropsychological processes, especially, of the executive functions, language, memory, orientation, concentration and attention. The aim of the investigation has been to verify the existence of cognitively significant manifestations, between groups, and the influence of emotional states and personality traits in these possible changes. Regarding its method, this has been descriptive and comparative study, with a quantitative approach, with the participation of 87 people, evenly divided into three groups: user group (G1), group of users in abstinence (G2), and non-user group (G3); evaluated in the neuropsychological field (NEUROPSI), and dimensions of: personality (NEO-FFI) and emotional regulation (DASS-21).
Statistically significant alterations were verified between consumers and abstainers, when compared with the control group, as well as, between the same groups of consumers and abstainers. And a significant influence on cognitive processing, due to emotional manifestations and personality traits. Among other findings, it can be mentioned that high levels of stress and anxiety affect the management of executive functions by 30%.
Downloads
References
Álvarez, Y., Cabrero, A., Abanades, S., & Farré, M. (2005). Metanfetaminas. Atención Primaria, 35(9): 445-502. https://doi.org/10.1157/13075482
Bagheri, M., Mokri, A., Khosravi, A., & Kabir, K. (2015). Effect of Abstinence on Depression, Anxiety, and Quality of Life in Chronic Methamphetamine Users in a Therapeutic Community. International journal of high risk behaviors & addiction, 4(3): 1-5. https://doi.org/10.5812/ijhrba.23903
Courtney, K. E., & Ray, L. A. (2014). Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and alcohol dependence, 143: 11–21. https://doi.org/10.1111/j.1360-0443.2009.02564.x.
Cruickshank, C., & Dyer, K. (2009). A review of the clinical pharmacology of methamphetamine. Addiction, 104(7),1085-99. https://doi.org/10.1111/j.1360-0443.2009.02564.x.
Da Silva, C. Y., Carvalho, P. A., Pombo, P. Gómez, J. F. (2019). Alteraciones neuropsicológicas asociadas al consumo de la Dextro-metil-anfetamina en adolescentes mexicanos. Revista Internacional de Investigación en Adicciones 5(1):15-22. https://doi.org/10.28931/riiad.2019.1.03.
Faraone, S. (2018). The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. Neuroscience Biobehavioral, 87: 255-270. https://doi.org/10.1016/j.neubiorev.2018.02.001.
Furlong, T, M., Corbit, L. H., Brown, R. A. & Balleine, B. W. (2017). Methamphetamine promotes habitual action and alters the density of striatal glutamate receptor and vesicular proteins in dorsal striatum. Addiction Biology, 23: 857–867. https://doi.org/10.1111/adb.12534
Gurrola Peña, G. M., Balcázar Nava, P., Bonilla Muños, M. P., & Virseda Heras, J. A. (2006).
Estructura factorial y consistencia interna de la escala de Depresión Ansiedad y Estrés (DASS-21) en una muestra no clínica. Psicología y Ciencia Social, 8(2), 3-7.
Janetsian, S. S., Linsenbardt, D. N. & Lapish, C. C. (2015). Memory impairment and alterations in prefrontal cortex gamma band activity following methamphetamine sensitization. Psychopharmacology, 232:2083–2095. https://doi.org/10.1007/s00213-014-3840-7.
King, G., Alicata, D., Cloak, C., & Chang, L. (2010). Neuropsychological deficits in adolescent methamphetamine abusers. Psychopharmacology, 212:243–249. https://doi.org/10.1007/s00213-010-1949-x
Lovibond, S. H., & Lovibond, P. F. (1995). Manual for the Depression Anxiety Stress Scales. 2nd. ed. Sydney: Psychology Foundation of Australia.
Milhorn, H. T. (2018). Substance Use Disorders. A Guide for the Primary Care Provider. Switzerland: Springer International Publishing AG.
Morais, A., Pita, I. R., Fontes-Ribeiro, C. A., & Pereira, F. C. (2018). The neurobiological mechanisms of physical exercise in methamphetamine addiction. CNS neuroscience & therapeutics, 24(2), 85–97. https://doi.org/10.1111/cns.12788
Moratalla, R., Khairnar, A., Simola, N., Granado, N., García-Montes, J. R., Porceddu, P. F., Tizabi, Y., Costa, G., & Morelli, M. (2017). Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms. Progress in Neurobiology, 155: 149–170. https://doi.org/10.1016/j.pneurobio.2015.09.011
Meda-Lara, R. M., Moreno-Jiménez, B., García, L. F., Palomera Chávez, A. & Mariscal de Santiago, M. V. (2015). Validez factorial del NEO-FFI en una muestra mexicana: Propuesta de una versión reducida. Revista Mexicana de Psicología, 32(1), 57-67.
Ostrosky, F., Ardila, A. & Roselli, M. (2013). Neuropsi: Evaluación Neuropsicológica Breve en español. México: Manual Moderno.
Ostrosky, F., Gómez, M. E., Matute, E., Rosselli, M., Ardila, A., & Pineda D. (2019). Neuropsi: Atención y Memoria (3a. ed.). México: Manual Moderno.
Owens, C. V., Mason, M. M., & Marr, D. (2017). Remediation of Manufactured Methamphetamine in Clandestine Laboratories. A Literature Review. Journal of chemical health & safety, 24(5), 23–37. https://doi.org/10.1016/j.jchas.2017.01.004
Pal, R., Mendelson, J., Clavier, O., Baggott, M. J., Coyle, J., & Galloway, G. P. (2016). Development and Testing of a Smartphone-Based Cognitive/Neuropsychological Evaluation System for Substance Abusers. Journal of Psychoactive Drugs 48(4): 288–294. http://dx.doi.org/10.1080/02791072.2016.1191093
Piñón, A., Lage, M., Carrera, I., Vázquez, M., Cerqueiro, X., Bobadilla, V., Spuch, C., & Otero, F. (2019). Perfil neuropsicológico y sintomatología psicopatológica de pacientes con trastornos relacionados con sustancias a tratamiento en una unidad de día. Health and Addictions, 19(1): 70-79.
Prakash, M., Tangalakis, K., Antonipillai, J., Stojanovska, L., Nurgali, K., Apostolopoulos, V. (2017). Methamphetamine: Effects on the brain, gut and immune system. Pharmacological Research. 120: 60-67. https://doi.org/10.1016/j.phrs.2017.03.009.
Román, F., Santibáñez, P., & Vinet, E. V. (2016). Use of the Depression Anxiety Stress Scales (DASS-21) as Screening Tests in Clinical Youngsters. Acta de Investigación Psicológica, 6(1), 2325-2336.
Sheridan, J., Bennett, S., Coggan, C., Wheeler, A. & McMillan, K. (2006). Injury associated with methamphetamine use: A review of the literature. Harm Reduction Journal, 3(14): 1-18. https://doi.org/10.1186/1477-7517-3-14.
Scott, J. C., Woods, S. P., Matt, G. E., Meyer, R. A., Heaton, R. K., Atkinson, J. H., & Grant. I. (2007). Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychology Review, 17(3):275-297. https://doi.org/10.1007/s11065-007-9031-0
Shukla, R. K. (2016). Methamphetamine: A Love Story. Oakland, California: University of California Press. https://doi.org/10.1177/0734016816679227
Somkuwar, S. S., Staples, M. C., Fannon, M. J., Ghofranian, A., & Mandyam, C. D. (2015). Evaluating Exercise as a Therapeutic Intervention for Methamphetamine Addiction-Like Behavior. Brain plasticity (Amsterdam, Netherlands), 1(1), 63–81. https://doi.org/10.3233/BPL-150007
Stock, A.K., Rädle, M., & Beste, C. (2018). Methamphetamine-associated difficulties in cognitive control allocation may normalize after prolonged abstinence. Prog Neuropsychopharmacol. Biological Psychiatry, 88: 41-52. https://doi.org/10.1016/j.pnpbp.2018.06.015
Thanos, P. K., Kim, R., Delis, F., Ananth, M., Chachati, G., Rocco, M. J., Masad, I., Muniz, J.A., Grant, S.C., Gold, M.S., Cadet, J.L., & Volkow, N. D. (2016). Chronic Methamphetamine Effects on Brain Structure and Function in Rats. PloS one, 11(6), e0155457. https://doi.org/10.1371/journal.pone.0155457
Widiger, T. A., & Costa Jr., P. T. (Eds.). (2013). Personality disorders and the five-factor model of personality. Washington, DC: American Psychological Association.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Revista AJAYU
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
De acuerdo a la Ley 1322 de Derechos de Autor en Bolivia, la revista de psicologia AJAYU respeta los derechos morales de los autores, amparando la parternidad e integridad de sus obras publicadas.
